Cardiokine

About:

Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of

Website: http://www.cardiokine.com

Top Investors: Ontario Teachers' Pension Plan, Aisling Capital, Eight Roads Ventures, HealthCare Ventures, Care Capital

Description:

Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004 and is headquartered in Philadelphia, Pennsylvania.